Citizens JMP Reiterates Market Outperform Rating on Crinetics (CRNX)

July 2, 2025 4:08 AM EDT Send to a Friend
Citizens JMP analyst Jonathan Wolleben reiterated a Market Outperform rating and $90.00 price target on Crinetics (NASDAQ: CRNX).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login